Recent research published in Frontiers in Pharmacology shows that CBD can reduce pains caused by incisions such as in surgical and oral procedures.
Leaders of the Senate Caucus on International Narcotics Control, Senator Dianne Feinstein (Calif.) and Chuck Grassley (Iowa), have introduced the Cannabidiol Research Expansion Act. This said new law will allow the support research on the potential benefits of CBD by allowing it to be conducted as a Schedule II registration.
Many adults suffer from anxiety disorders and end up taking medications such as xanax, antidepressants, and supplements. On occasion they also try meditation and deep breathing to help cope with their condition. Cannabis, however, has been a recently discovered aid that can also help. Research shows that the chemical compound found in cannabis known as CBD is overall a powerful treatment for illnesses and disorders such as these.
For thousands of years, Cannabis and Cannabinoids have been used for medical purposes, and today cannabis is becoming more and more popular as a method to treat a wide variety of cancers. Cannabis and CBD have been shown to relieve pain, nausea and vomiting, increase appetite, decrease anxiety as well as lower inflammation. All of which are typical symptoms associated with cancer.
According to recent research conducted in animals, CBD may improve schizophrenia-specific cognitive impairment without the current side effects that are normally experienced with medicine. The symptoms of schizophrenia are usually categorized as being positive, negative or cognitive. Cognitive problems include difficulty concentrating, making decisions, as well as problems with comprehending and using new information.
Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced that its subsidiary HempMeds Mexico will reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.